MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application…
Latest Articles
-
-
The Government of Ontario started taking applications for resource development projects under its “One Project, One Process” framework on Friday (October 17). The…
-
This week was marked by strong, event-driven volatility across the tech sector. Market moves were shaped by artificial intelligence (AI) infrastructure announcements, semiconductor…
-
Investing
Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units
by admin/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ finlay minerals ltd. (TSXV: FYL,OTC:FYMNF) (OTCQB: FYMNF) (‘Finlay’ or the ‘Company’)…
-
MILAN — Giorgio Armani has appointed deputy managing director Giuseppe Marsocci as chief executive with immediate effect, the Italian fashion house said on…
-
RemSense Technologies (REM:AU) has announced Strategic Entry into Australian Gas Infrastructure Sector Download the PDF here. This post appeared first on investingnews.com
-
Don Durrett of GoldStockData.com outlines current gold and silver market dynamics, explaining why the metals continue to rise and how high they could…
-
Corazon Mining (CZN:AU) has announced Completes Two Pools Gold acquisition Download the PDF here. This post appeared first on investingnews.com
-
Carbonxt Group (CG1:AU) has announced Convertible Note and Placement Download the PDF here. This post appeared first on investingnews.com
-
It’s been yet another historic week for gold and silver, with both setting new price records. The yellow metal broke through US$4,200 per…